Sign in
4

Changes in Ownership

Opus Genetics, Inc. Filed Acc 0001140361-17-002737

Options or other derivatives

  • Chief Financial Officer acquired 363,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Jeong Tae Heum · Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-01-20 Grant or award : show line 1 in the form Stock Option (right to buy) +300,000 $0.18 2027-01-20 300,000 300,000 D
2017-01-20 Grant or award : show line 2 in the form Restricted Stock Units +63,000 63,000 63,000 D
Loading xslF345X03/form4.xml…